z-logo
Premium
Barriers to prescribing cannabis‐based medicines
Author(s) -
Dowden Angela
Publication year - 2019
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1774
Subject(s) - medicine , cannabis , schedule , government (linguistics) , meaning (existential) , alternative medicine , psychiatry , family medicine , traditional medicine , psychotherapist , management , psychology , linguistics , philosophy , pathology , economics
Last November, the government moved cannabis‐based medicinal products out of Schedule 1 into Schedule 2 of the Misuse of Drugs Regulations, meaning they can now legally be prescribed. However, conflicting advice from different authorities, sourcing difficulties and a lack of guidelines have meant that few patients have so far been able to access these medicines.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here